Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Glycation of apoprotein A-I is associated with coronary artery plaque progression in type 2 diabetic patients.

Pu LJ, Lu L, Zhang RY, Du R, Shen Y, Zhang Q, Yang ZK, Chen QJ, Shen WF.

Diabetes Care. 2013 May;36(5):1312-20. doi: 10.2337/dc12-1411. Epub 2012 Dec 10.

2.
3.

The impact of coronary artery disease risk factors on intravascular ultrasound-derived morphologic indices of human coronaries.

Kahlon JP, Torey J, Nordstrom CK, LaLonde TA, Ali A, Schreiber TL, Ogawa T, Maciejko JJ, Rosman H, Gardin JM.

Echocardiography. 2006 Apr;23(4):308-11.

PMID:
16640708
4.

Diagnostic accuracy of dual-source CT angiography and coronary risk stratification.

Yang X, Gai LY, Li P, Chen YD, Li T, Yang L.

Vasc Health Risk Manag. 2010 Oct 21;6:935-41. doi: 10.2147/VHRM.S13879.

5.

Subclinical coronary artery disease in patients with type 1 Diabetes Mellitus undergoing hemodialysis.

Oliveira DC, Brito Junior FS, Fernandes RW, Sa JR, Lima VC.

Arq Bras Cardiol. 2009 Jul;93(1):15-21. English, Portuguese, Spanish.

6.

Decreased serum esRAGE level is associated with angiographically determined coronary plaque progression in diabetic patients.

Peng WH, Lu L, Hu J, Yan XX, Zhang Q, Zhang RY, Chen QJ, Shen WF.

Clin Biochem. 2009 Aug;42(12):1252-9. doi: 10.1016/j.clinbiochem.2009.04.017. Epub 2009 May 8.

PMID:
19439163
7.

Chromosome 9p21.3 polymorphism in a Chinese Han population is associated with angiographic coronary plaque progression in non-diabetic but not in type 2 diabetic patients.

Wang W, Peng W, Zhang X, Lu L, Zhang R, Zhang Q, Wang L, Chen Q, Shen W.

Cardiovasc Diabetol. 2010 Aug 6;9:33. doi: 10.1186/1475-2840-9-33.

8.

Impact of tissue characteristics on luminal narrowing of mild angiographic coronary stenosis: assessment of integrated backscatter intravascular ultrasound.

Iwama M, Tanaka S, Noda T, Segawa T, Kawasaki M, Nishigaki K, Minagawa T, Watanabe S, Minatoguchi S.

Heart Vessels. 2014 Nov;29(6):750-60. doi: 10.1007/s00380-013-0428-9. Epub 2013 Oct 24.

PMID:
24154856
9.

Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.

Berry C, L'Allier PL, Grégoire J, Lespérance J, Levesque S, Ibrahim R, Tardif JC.

Circulation. 2007 Apr 10;115(14):1851-7. Epub 2007 Mar 26.

10.

Relationship of coronary artery plaque composition to coronary artery stenosis severity: results from the prospective multicenter ACCURACY trial.

Min JK, Edwardes M, Lin FY, Labounty T, Weinsaft JW, Choi JH, Delago A, Shaw LJ, Berman DS, Budoff MJ.

Atherosclerosis. 2011 Dec;219(2):573-8. doi: 10.1016/j.atherosclerosis.2011.05.032. Epub 2011 May 31.

PMID:
21696739
11.

Coronary plaque progression of non-culprit lesions after culprit percutaneous coronary intervention in patients with moderate to advanced chronic kidney disease: intravascular ultrasound and integrated backscatter intravascular ultrasound study.

Kashiyama K, Sonoda S, Muraoka Y, Suzuki Y, Kamezaki F, Tsuda Y, Araki M, Tamura M, Takeuchi M, Abe H, Okazaki M, Fujino Y, Otsuji Y.

Int J Cardiovasc Imaging. 2015 Jun;31(5):935-45. doi: 10.1007/s10554-015-0633-y. Epub 2015 Feb 28.

12.

ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies.

Nicholls SJ, Gordon A, Johannson J, Ballantyne CM, Barter PJ, Brewer HB, Kastelein JJ, Wong NC, Borgman MR, Nissen SE.

Cardiovasc Drugs Ther. 2012 Apr;26(2):181-7. doi: 10.1007/s10557-012-6373-5.

PMID:
22349989
13.

Volumetric intravascular ultrasound imaging to illustrate the extent of coronary plaque burden in type 2 diabetic patients.

Schukro C, Syeda B, Yahya N, Gessl A, Holy EW, Pichler P, Derntl M, Glogar D.

J Diabetes Complications. 2007 Nov-Dec;21(6):381-6.

PMID:
17967711
14.

Association between serum galectin-3 levels and coronary atherosclerosis and plaque burden/structure in patients with type 2 diabetes mellitus.

Ozturk D, Celik O, Satilmis S, Aslan S, Erturk M, Cakmak HA, Kalkan AK, Ozyilmaz S, Diker V, Gul M.

Coron Artery Dis. 2015 Aug;26(5):396-401. doi: 10.1097/MCA.0000000000000252.

PMID:
25887000
15.

Carotid artery plaque and LDL-to-HDL cholesterol ratio predict atherosclerotic status in coronary arteries in asymptomatic patients with type 2 diabetes mellitus.

Fujihara K, Suzuki H, Sato A, Kodama S, Heianza Y, Saito K, Iwasaki H, Kobayashi K, Yatoh S, Takahashi A, Yamada N, Sone H, Shimano H.

J Atheroscler Thromb. 2013;20(5):452-64. Epub 2013 Jan 30.

16.

HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.

Tani S, Nagao K, Hirayama A.

Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000.

PMID:
22149320
17.

Diabetes as an independent predictor of high atherosclerotic burden assessed by coronary computed tomography angiography: the coronary artery disease equivalent revisited.

de Araújo Gonçalves P, Garcia-Garcia HM, Carvalho MS, Dores H, Sousa PJ, Marques H, Ferreira A, Cardim N, Teles RC, Raposo L, Gabriel HM, Almeida M, Aleixo A, Carmo MM, Machado FP, Mendes M.

Int J Cardiovasc Imaging. 2013 Jun;29(5):1105-14. doi: 10.1007/s10554-012-0168-4. Epub 2012 Dec 13.

PMID:
23239217
18.

Comparison of optical coherence tomography and intravascular ultrasound for evaluation of coronary lipid-rich atherosclerotic plaque progression and regression.

Xie Z, Tian J, Ma L, Du H, Dong N, Hou J, He J, Dai J, Liu X, Pan H, Liu Y, Yu B.

Eur Heart J Cardiovasc Imaging. 2015 Dec;16(12):1374-80. doi: 10.1093/ehjci/jev104. Epub 2015 Apr 24.

PMID:
25911116
19.

[Quantitative coronary angiography and intravascular ultrasound assessments on target lesion and reference vessel in patients with diabetes mellitus].

Jin ZN, Lü SZ, Chen YD, Yuan F, Song XT, Wu XF, Zhang LJ, Ren F, Ge CJ, Wang GZ, Xu XW.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Aug;37(8):721-4. Chinese.

PMID:
20021925
20.

Supplemental Content

Support Center